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ABSTRACT
Pathogenic bacteria employ many strategies to overcome the host immune system for extended survival
and propagation in their hosts. Components of the bacterial outer-membrane play an important role in
this process. When invading the host, Gram-negative bacteria often use a strategy, known as phase
variation, that involves a reversible change in antigenic determinants, frequently polysaccharides. This
means that the genes encoding the outer-membrane antigens undergo reversible changes within
repeated simple DNA sequence motifs. The antigenic structure of the bacterial outer-membrane is
inﬂuenced by the character of the host immune system, as well as by the targets for bacterial invasion.
When the selection pressure of the immune system is absent or weak, bacteria can fail to synthesise the
outer-membrane antigens, which are not needed at that time. Smooth-to-rough (S-R) mutation, an
economical and often irreversible process in some Gram-negative bacteria, involves the gradual
shortening of the lipopolysaccharide (LPS) O-chain. Under certain conditions, e.g., propagation in
embryonated eggs or cell lines, some bacteria will cease synthesis of the complete LPS O-chain because it
is an energy-demanding process. A type of gradual shortening of the LPS O-chain by Coxiella burnetii,
traditionally called phase variation, is used in serological tests for the diagnosis of Q fever. This review
discusses the role and function of polysaccharides, especially LPS produced by some Gram-negative
bacteria, in bacterial survival.
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INTRODUCTION
Pathogenic bacteria invading a host are under
strong selective pressure from the host immune
system and use a range of different strategies to
escape its destructive effects. Bacteria can even
change the structure of their outer-membrane
components depending on the target for invasion,
e.g., skin, blood or inner organs. This is a
consequence of high-frequency reversible on–off
switching of phenotypic expression, which also
inﬂuences the potential for bacterial pathogenic-
ity. Examples are Gram-negative bacteria, in
which lipopolysaccharide (LPS), with lipid A as
its endotoxic component and a structurally ver-
satile O antigen (O-chain), is known to be an
important virulence factor [1]. The O-chain, which
is the exposed part of LPS, is a highly variable
surface antigen [2]. If the bacterium lives in the
absence of any immune system intervention or
stress, it can adapt to this environment, and
certain bacteria may even stop the synthesis of
some protective compounds that are necessary for
survival under more ‘difﬁcult’ circumstances.
This is the case for the smooth-to-rough (S-R)
mutations of enteric Gram-negative bacteria,
which gradually stop the synthesis of the LPS
O-chain, as this is an energy-demanding process.
However, the genetic deletions found in R
mutants can also be irreversible. Although they
save the expenditure of unnecessary energy, these
mutants are not able to start the reverse process
under changed environmental circumstances.
Both processes, i.e., high-frequency reversible
on–off switching of phenotypic expression and
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step-by-step S-R mutations, are bacterial re-
sponses to changing conditions brought about
by the host immune system.
ON–OFF SWITCHING OF
PHENOTYPIC EXPRESSION
High-frequency reversible on–off switching of
phenotypic expression of cell surface components
(phase variation) is a common feature of many
virulence determinants. Bacteria have a range
of phase-variable mechanisms, but not all
phase-variable genes are associated with outer-
membrane antigens [3]. Genetic diversity and
mutations in bacteria may also have unfavourable
consequences [4]. Phase variation is associated
with reversible changes within repeated simple
DNA sequence motifs that exhibit high mutation
rates by loss or gain of repeat units during DNA
replication. The switch can be inﬂuenced by the
extracellular conditions. Such reversible changes
are heritable and reversible between generations,
and the switching frequency is characteristic for
the gene, the bacterial species and the regulatory
mechanism [5]. The mechanisms involved in
on–off switching of target genes include genomic
rearrangement, slipped-strand mispairing (SSM),
or variation mediated by differential methylation
that changes the expression of a bacterial genome
component sequence [6]. Saunders et al. [7]
described an analysis approach used to identify
DNA sequence motifs within a complete bacterial
genome sequence. This approach can identify and
locate sequence repeats with motifs of 1–10 bases
repeated at least ﬁve times, and allows detection
of candidate genes for phase variation.
The most-studied pathogenic organisms that
express this type of phase variation are Neisseria
spp., Haemophilus inﬂuenzae, Campylobacter jejuni
and Helicobacter pylori. Of these, Neisseria menin-
gitidis and Neisseria gonorrhoeae are phase-variable
human pathogens that have been studied exten-
sively. Outer-membrane components, e.g., pili [8],
LPS [9], outer-membrane proteins, capsules and
haemoglobin receptors [10], of these bacteria
show high-frequency variations in their expres-
sion. LPS of Neisseria, as well as that of Haemo-
philus, does not possess an O-chain.
The range of phase variation possibilities for
N. meningitidis is illustrated in the study by
Martin et al. [11], which identiﬁed 33 potentially
phase-variable genes in N. meningitidis strain
MC58. Bacterial structures that come into contact
with parts of the host immune system can change
their antigenic determinants in accordance with
their immediate situation, thereby increasing
antigenic variability and virulence, and concom-
itant penetration into the host organs. LPS con-
tains terminal units that can quickly change from
one structure to another. Investigation of clinical
isolates of meningococci has revealed a wide LPS
repertoire.
The phase-variable nature of the biosynthesis of
LPS molecules produces a mixed population of
organisms with respect to their genotype and
phenotype [9]. Invasive strains of N. meningitidis
are able to exchange DNA by transformation and
recombination [12], and possess sophisticated
mechanisms for adaptation to a rapidly changing
microenvironment in the host, depending on
locality, e.g., nasopharynx, blood or the central
nervous system (with or without pili and cap-
sules). Several mechanisms of N. meningitidis
capsular phase variation have been described.
The synthesis of capsular polysaccharides is
increased in clinical isolates from patients with
invasive disease, and is down-regulated in
N. meningitidis isolates recovered from the naso-
pharynx [10].
A single strain of N. gonorrhoeae can produce a
limited repertoire of LPS molecules that are
required for passing through the human mucosal
barrier [13]. However, LPS phase variation during
natural infection has also been associated with
another phase-variable surface component in
order to create an invasive gonoccocal phenotype.
N. gonorrhoeae uses sialylation of LPS to mediate
its entry into epithelial cells and for serum
resistance [14]. N. gonorrhoeae LPS containing
low amounts of sialic acid allows the entry of
the bacterium into human mucosal epithelial
cells, whereas variants with highly sialylated
LPS resist killing by complement and antibodies,
but fail to enter human mucosal epithelial cells.
There are differences in the expression of sialyl-
transferase between N. gonorrhoeae and N. menin-
gitidis, with N. gonorrhoeae expressing
signiﬁcantly more sialyltransferase than N. men-
ingitidis [15].
Inter- and intra-strain heterogeneity is demon-
strated by the LPS produced by H. inﬂuenzae.
Different LPS surface structures produce
phase-variants of LPS, which is a principal com-
ponent of the H. inﬂuenzae outer-membrane,
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following interactions with the host immune
system. O-acetylation of LPS is also subject to
phase variation. Such acetylation would contrib-
ute to the hydrophobicity of LPS, which the
bacterium can utilise during infection of the
human respiratory tract [16]. Phase variation in
LPS also correlates with phase-variable resis-
tance–sensitivity to phage infection [17]. A possi-
ble molecular mechanism for the control of this
high-frequency spontaneous gain or loss of epi-
topes is similar to that used by Neisseria [18,19].
Variation in the number of CAAT hyper-mutable
repeated sequences in genomic loci lic-1 and lic-2,
which encode enzymes involved in the synthesis
of LPS, can generate a translational switch [20,21].
The phase-variants produced during the course of
infection also enhance the virulence of the bac-
terium. An individual strain of H. inﬂuenzae can
express one or more glycosyl transferases, and
H. inﬂuenzae phase variation mediated by tandem
octanucleotide repeats within the losA gene has
been described [22].
The wide variety of ways in which phenotypic
expression can be altered in the bacterial world
has been reviewed previously by Torres-Cruz and
van der Woude [23]. These authors described the
possibility of length variation of short repetitive
DNA sequences in Escherichia coli as a result of
SSM, mediated by the SSM-containing regions of
H. inﬂuenzae. The SSM-containing regions were
ampliﬁed from H. inﬂuenzae genomic DNA and
integrated into the E. coli chromosome in the form
of a recombinant phage.
High-frequency phase variation observed in the
expression of capsule by a C. jejuni strain pro-
vides a demonstration of the glycan structure
variation in the capsule produced by this patho-
gen. The loss of expression of high molecular
mass glycan is the result of an insertion into the
kpsM gene. This insertion increased the serum
sensitivity and reduced the virulence of this
particular strain of C. jejuni [24].
H. pylori has to survive the acidic environment
of the human stomach in which it resides. Phase
variation of H. pylori genes may contribute to
evasion, colonisation and persistent infection of
the stomach. Most LPS biosynthetic genes in
H. pylori are associated with phase variation,
and the genetic location of these genes can vary
among strains. Of eight sequenced LPS biosyn-
thetic genes, seven were associated with phase
variation [25]. The O-chain of H. pylori LPS
contains fucosylated oligosaccharides and the
Lewis antigens, which mimic human blood group
antigens. The expression of these antigens may be
variable within the cell population of a single
strain [26]. This type of antigenic variation is
probably important for H. pylori during long-term
colonisation. It is possible that the Lewis antigens
continually change their phase, and that the
expression of certain antigens is beneﬁcial for
colonisation and infection. It has been shown that
a rough LPS mutant of H. pylori without an
O-chain has reduced colonising ability [27].
Phase variation in H. pylori also affects mem-
brane lipid composition. The switch of H. pylori
membrane lipid composition genes is spontane-
ous and reversible, and is associated with a
change in the membrane phospholipids, from a
low content of lysophospholipids in one variant
(normal L variant) to a high content in another
variant (lyso-S variant). Prolonged growth at
pH 3.5 results in an almost complete conversion
to the S variant. L variants survive and grow at
pH 5.0, whereas only a few colonies are formed at
pH 3.5, all of them as S variants. The change in
membrane lipid composition is caused by phase
variation in the pldA gene, which encodes the
outer-membrane phospholipase. Variants with
active phospholipase are better able to survive
acidic conditions. The change from L to S colonies
in H. pylori seems to be independent of the LPS
variation, although shortening of LPS from
smooth to rough LPS always followed the switch
from L to S morphology. However, the rough LPS
was retained after the reverse switch from the S to
L variant [28].
Phase variation in Franciscella novicida LPS also
affects the antigenic structure of the O-chain.
Regulation of O-chain length in Franciscella spp.
seems to be essential for serum resistance aswell as
for intracellular growth. The reversible LPS phase
variation occurred following diminished expres-
sion of one type of LPS thatwas unable to stimulate
nitric oxide production in rat macrophages, with
expression of a different type of LPS that induces
nitric oxid production in rat macrophages [29,30].
Some bacteria are able to form plasmids that
carry certain genetic elements as a reserve source
of genetic material for changing their virulence.
A study of the molecular mechanism of LPS phase
variation in Legionella pneumophila has revealed an
unstable 30-kb genetic element of phage origin.
Whereas the 30-kb element was located on the
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chromosome in the virulent wild-type strain, its
excision from the chromosome and replication as
a high-copy-number plasmid resulted in a mutant
phenotype, characterised by alteration of an LPS
epitope and loss of virulence. However, the
mutant phenotype could revert to the wild-type
by re-insertion of the 30-kb element into the
chromosome [31].
S-R MUTATION
The types of phase variation described above, all
of which are associated with high-frequency
spontaneous gain and loss of antigenic LPS
epitopes, are all reversible. Other changes in the
structure of the outer-membrane involve irrevers-
ible changes in the polysaccharide molecules of
some Gram-negative bacteria. These include
mutations resulting in successive antigenic dele-
tions in LPS, but some proteins in the bacterial
outer-membrane can also be affected. The degen-
erative process in this case consists of a step-by-
step mechanism that results in the outer O-chain
of LPS decreasing in length.
Examples of such changes can be seen in the
LPS structure of enteric bacteria. The genes for the
synthesis of the core and O-chain LPS in Entero-
bacteriacae are organised in contiguous clusters.
In E. coli and Salmonella enterica Typhimurium,
these clusters are present in two regions of the
chromosome [32]. Following intervention of the
host immune system, the S-form of bacterial
colonies, possessing complex LPS structures with
a complete O-chain and full antigenic structure,
are present. The R-form appears in the absence of
an effective host immune system, or following
propagation in vitro, and contains truncated LPS
with a varying core structure, the synthesis of
which requires less expenditure of energy by the
bacterial cell. In addition to alterations in the
structure of the LPS, the degenerative process
includes deep changes in the outer-membrane,
with a dramatic reduction in the number of porin
proteins, particularly OmpA [33]. LPS is associ-
ated closely with the trimeric OmpF and LamB
proteins of the outer-membrane, which enable
diffusion of substrates into and out of the cell.
Therefore, the S-R variation also inﬂuences the
content of surface proteins. In deep R mutants of
E. coli, the rate of porin assembly was retarded in
comparison with the rate observed in the wild-
type strain [34].
The interaction between S-LPS and Omp pro-
teins in E. coli is stronger than that observed for R-
LPS–protein complexes of Acinetobacter calcoaceti-
cus [35]. The mobility and banding pattern of
OmpF porin trimers of E. coli in SDS-PAGE are
inﬂuenced by the chemotype of the associated
LPS. OmpF molecules associated with S-LPS
migrate with a slower mobility in electrophoresis
gels than that of R-LPS [36]. The genetic nature of
the deep R mutants in enteric bacteria is now
well-understood, in that mutations resulting in
defects in the backbone heptose region of the
inner core affect modiﬁcation of this region [37].
However, the mutations in other Gram-negative
bacteria have not been so thoroughly studied. All
clinical isolates of H. pylori have S-LPS with
O-chains of relatively homogeneous length, but
H. pylori strains from culture collections show
SDS-PAGE proﬁles with R-LPS [38].
A good example of step-by-step mutation is the
LPS of the obligate intracellular pathogen Coxiella
burnetii, a close relative of L. pneumophila, which is
the causative agent of Q fever in humans [39].
Wild-type C. burnetii strains possess a typical
Gram-negative outer-membrane, with a complex
structure of LPS, proteins and phospholipids. The
degenerative mutations in C. burnetii LPS are
traditionally referred to in the scientiﬁc literature
as ‘phase variation’, and phase I and phase II LPS
molecules have been distinguished. Phase I LPS
(S-like form) is a complete LPS molecule with
O-chain saccharidic units that is typical of wild-
type C. burnetii strains. Phase variation is
employed in the diagnosis of Q fever. During
acute Q fever, C. burnetii induces antibodies
against phase II (protein antigens), while chronic
Q fever, often manifested as endocarditis, is
associated with the production of high titres of
antibodies directed against phase I (LPS antigen)
[40]. Following repeated passage in chick embryo
yolk sacs or in cell lines, i.e., in the absence of
immune system intervention, C. burnetii wild-
type strains convert to phase II and produce the
R-like form of LPS. Results of SDS-PAGE and
immunoblot analysis have shown that the LPS of
C. burnetii shows a gradual shortening of its
O-chain following repeated passage [41].
C. burnetii strains with higher numbers of pas-
sages in chick embryo yolk sacs had decreased
antigenic properties and virulence against guinea-
pigs and mice [42], but there was no difference in
phase-variation steps between C. burnetii strains
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of high and low virulence [43]. It can be specu-
lated that phase variation in C. burnetii resembles
the S-R mutation process observed in Enterobac-
teriaceae. However, studies of phase I and II
C. burnetii proteins using SDS-PAGE have failed
to reveal any signiﬁcant decrease in the protein
content during phase variation [44,45]. These
results indicate differences between C. burnetii
phase variation and the S-R mutations found in
enteric bacteria, where the decrease in the porin
protein content in the R-form is clearly apparent
(see above).
Hotta et al. [46] studied phase variation in
C. burnetii with three types of monoclonal anti-
bodies. Four C. burnetii groups were distin-
guished during serial passages of C. burnetii in
cell lines, and other antigenic groups could be
distinguished upon further passaging. Vodkin
and Williams [47] found large chromosomal
deletions associated with phase variation in
C. burnetii LPS, and it seems that DNA deletions
are a characteristic feature of the generation of
phase II variants of C. burnetii. When mapping
the deletion in the O-antigen cluster in two
antigenic variants of the Nine Mile strain of
C. burnetii, the deleted sequences in both variants
were revealed to be in genes involved in the
biosynthesis of speciﬁc sugars forming part of the
O-chain [48]. Phase II deletions have now been
characterised in 14 isolates of C. burnetii by
microimmunoﬂuorescence tests and PCR ampli-
ﬁcation of selected open reading frames impor-
tant for O-chain biosynthesis [49]. Phase I isolates
did not display deletions in this region but, as
expected, some phase II isolates contained large
deletions in LPS biosynthesis genes. However,
other phase II isolates did not contain such
deletions, and it has been suggested that LPS
truncation in such cases can occur via small
genetic changes [50]. Data from comparative
genome hybridisation studies have revealed that
truncated LPS is fully responsible for the aviru-
lence of the Nine Mile phase II strain, since
deletions of open reading frames in other regions
were not detected. Further genetic studies of
phase II isolates without large deletions in the
LPS biosynthesis genes will help to explain their
outer-membrane antigenic structure. It is known
that phase I LPS of C. burnetii possesses low anti-
genic and immunogenic properties [51] and thus
the phase I LPS–protein complex of C. burnetii is
used as a vaccine against Q fever [52].
CONCLUSIONS
Pathogenic bacteria have developed many strat-
egies to avoid attack by the host immune system.
One of these is phase variation, which enables a
change in virulence factors according to the
environmental situation and the needs of the
bacterium, but without increasing the overall
mutability of the remainder of the genome. Thus,
phase variation is a way to maximise the chance
of survival during host colonisation and propa-
gation. This reversible process is characteristic of
mostly surface-associated antigens, e.g., LPS, cap-
sule and glycosylated pili, but also for outer-
membrane proteins, encoded by contingency
genes that have key roles in invasion and coloni-
sation.
In contrast, S-R mutation is a step-by-step
process that results in an irreversible change. The
resulting R mutants are unable to revert to their
original state, and fail to survive in a host with an
intact immune system. The so-called phase varia-
tion observed in C. burnetii is misnamed, as it
actually involves a process resembling S-R muta-
tion, except for the preservation of outer-mem-
brane proteins that show a signiﬁcant decrease
following S-R mutation of enteric bacteria.
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